IFITM1 and hepatocellular carcinoma: In conclusion, we showed for the first time that AT-MSCs enhanced the efficacy of radiotherapy in HCC cell in vitro by silencing IFITM1 expression and significant delaying the growth of HCC tumors in vivo.